BFM
SPRB

Boothbay Fund Management’s Spruce Biosciences SPRB Stock Holding History

Boothbay Fund Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Hold
42,080
– – 0.03% 669
2026
Q1 		$2.75M Sell
42,080
-5,853
-12% -$404K 0.04% 500
2025
Q4 		$4.18M Buy
+47,933
New +$5.14M 0.06% 340
2025
Q2 		– Sell
-3,851
Closed -$83.8K – 1852
2025
Q1 		$83.8K Hold
3,851
– – ﹤0.01% 1239
2024
Q4 		$121K Buy
+3,851
New +$141K ﹤0.01% 1259

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Boothbay Fund Management's SPRB Position: Q2 2026 in Review

Boothbay Fund Management held its Spruce Biosciences (SPRB) position steady in Q2 2026 at 42,080 shares worth $2.27M. The position accounts for 0.03% of the portfolio, ranked #669.

Boothbay Fund Management first reported a position in SPRB in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.18M in Q4 2025. 64 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Boothbay Fund Management held 42,080 shares of Spruce Biosciences worth $2.27M as of Q2 2026.
  • Boothbay Fund Management left its Spruce Biosciences share count unchanged in Q2 2026.
  • Spruce Biosciences made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #669 holding.
  • Boothbay Fund Management first reported a position in Spruce Biosciences in Q4 2024 and has held it in 5 quarters since.
  • Boothbay Fund Management's Spruce Biosciences position peaked at $4.18M in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.